The International Max Planck Research School for Translational Psychiatry (IMPRS-TP) provides first class training in cellular and systemic psychiatric research. Students are exposed to a wide range of scientific questions and methods covering areas of molecular medicine, neuroscience, psychiatry, neuroimaging, design-based stereology and clinical studies.
In addition to the traditional doctorate positions, trainee medical doctors are given the opportunity to be enrolled on an integrated PhD/residence program in psychiatry. Highlighting the translational facet, doctorate students will receive insights into clinical aspects of disease and trainee medical doctors will gain PhD level research expertise, while also developing their clinical skills.
The structured curriculum addresses topics ranging from molecular and cellular neuroscience, behavioural assessments, electrophysiology and brain imaging to psychological and clinical measures and outcomes, as well as, epidemiology, statistics and bioinformatics.
IMPRS-TP is a joint initiative of leading scientists from the Max Planck Institute of Psychiatry, the Max Planck Institute of Neurobiology and the Ludwig Maximilians University, Munich. Further collaborations have been established with the Munich Medical Research School (MMRS) and the Graduate School of Systemic Neurosciences (GSN). IMPRS-TP is co-funded by the Else-Kröner-Fresenius Foundation.